LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated pathogen detection platform in the life sciences and diagnostics industries. The company's platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. Its technology aims to transform the way organizations prevent and diagnose disease in various markets, such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and more. The company is headquartered in Beverly, Massachusetts.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone800-215-1824
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees20
Next Earnings DateN/A
OptionableNot Optionable
Lexagene (CVE:LXG) Frequently Asked Questions
What is Lexagene's stock symbol?
Lexagene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LXG."
Has Lexagene been receiving favorable news coverage?
News coverage about LXG stock has trended somewhat negative recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Lexagene earned a daily sentiment score of -1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Lexagene.
Who are some of Lexagene's key competitors?
Some companies that are related to Lexagene include Profound Medical (PRN), Yourgene Health (YGEN), Oncosil Medical (OSL), BARD1 Life Sciences (BD1), MaxCyte (MXCT), Oncimmune (ONC), Sernova (SVA), SQI Diagnostics (SQD), GeneNews (GEN), Deepmatter Group (DMTR), Imagion Biosys (IBX), LED Medical Diagnostics (LMD), Dorsavi (DVL), VentriPoint Diagnostics (VPT) and Genedrive (GDR).
What other stocks do shareholders of Lexagene own?
Who are Lexagene's key executives?
Lexagene's management team includes the folowing people:
- Dr. John F. Regan, Founder, Chairman & CEO
- Mr. Darrel M. Rebeck, Pres & Director
- Mr. Jeffrey Mitchell, Chief Financial Officer
- Mr. Allan Fabbro, VP of Corp. Devel.
How do I buy shares of Lexagene?
Shares of LXG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Lexagene's stock price today?
One share of LXG stock can currently be purchased for approximately C$0.50.
How big of a company is Lexagene?
What is Lexagene's official website?
How can I contact Lexagene?
The company can be reached via phone at 800-215-1824.
MarketBeat Community Rating for Lexagene (CVE LXG)
MarketBeat's community ratings are surveys of what our community members think about Lexagene and other stocks. Vote "Outperform" if you believe LXG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LXG will underperform the S&P 500 over the long term. You may vote once every thirty days.
